Alemtuzumab (Campath-1H) for treatment of refractory polymyositis
Thompson, B.; Corris, P.; Miller, J.A.L.; Cooper, R.G.; Halsey, J.P.; Isaacs, J.D.
Journal of Rheumatology 35(10): 2080-2082
2008
ISSN/ISBN: 0315-162X PMID: 18843768 Document Number: 618445
Document emailed within 1 workday
Related Documents
Mok, C.Chiu.; Ho, L.Yin.; To, C.Hung. 2007: Rituximab for refractory polymyositis: an open-label prospective study Journal of Rheumatology 34(9): 1864-1868Adams, E.M.; Pucino, F.; Yarboro, C.; Hicks, J.E.; Thornton, B.; McGarvey, C.; Sonies, B.C.; Bartlett, M.L.; Villalba, M.L.; Fleisher, T.; Plotz, P.H. 1999: A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures Journal of Rheumatology 26(2): 352-360
Ueki, D.; Yoshida, C.; Tsutsumi Oota, I.; Seki, M.; Komeno, T.; Ito, H.; Ide, Y. 2019: Successful Treatment of T-Cell Prolymphocytic Leukemia with Alemtuzumab Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(5): 913-915
Tada, Y.; Suematsu, E.; Ueda, A.; Nagano, S.; Sawabe, T.; Nishizaka, H.; Horiuchi, T. 2012: Clinical factors to predict a poor prognosis and refractory disease in patients with polymyositis and dermatomyositis associated with interstitial lung disease Clinical and Experimental Rheumatology 30(3): 450
Irlé, C.; Kaestli, M.; Aapro, M.; Chapuis, B.; Jeannet, M. 1987: Quantity and nature of residual bone marrow T cells after treatment of the marrow with Campath-1 Experimental Hematology 15(2): 163-170
Saito, E.; Yoshimoto, Y.; Oshima, H.; Yoshida, H.; Kinoshita, M. 1989: Fluorescent antibodies in polymyositis using cultured human skin fibroblasts: granular perinuclear cytoplasmic staining pattern by sera from patients with polymyositis and pulmonary fibrosis Journal of Rheumatology 16(1): 47-54
Stilgenbauer, S. 2008: Advances in the use of alemtuzumab in CLL Clinical Advances in Hematology and Oncology: H&o 6(1): 23-24
Nau, J.-Y. 2008: Alemtuzumab and multiple sclerosis Revue Medicale Suisse 4(178): 2425
Targoff, I.N. 1990: Diagnosis and treatment of polymyositis and dermatomyositis Comprehensive Therapy 16(4): 16-24
Matthiesen, J. 1979: Polymyositis as a possible complication of cimetidine treatment Ugeskrift for Laeger 141(40): 2762-2763
Mehregan, D.R.; Su, W.P. 1993: Cyclosporine treatment for dermatomyositis/polymyositis Cutis 51(1): 59-61
Sokolov, A.H.; Parovichnikova, E.N.; Isaev, V.G.; Ustinova, E.N.; Shavlokhov, V.S.; Atopkov, V.A.; Model, S.V.; Tsyba, N.N.; Kaplanskaia, I.B.; Kliasova, G.A.; Aleksanian, M.Z.; Vishnevskaia, E.S.; Togonidze, D.K.; Mirzoian, E.E.; Savchenko, V.G. 2004: A case of effective use of alemtuzumab in a male patient with T-cell lymphoma Terapevticheskii Arkhiv 76(12): 73-75
Rovenský, J.; Zitnan, D.; Lukác, J.; Tauchmannová, H. 1982: Effect of levamisole treatment in polymyositis patients Journal of Rheumatology 9(1): 158-159
Uchino, M.; Araki, S.; Yoshida, O.; Uekawa, K.; Nagata, J. 1983: Efficacy of alternate-day corticosteroid administration in the treatment of polymyositis Rinsho Shinkeigaku 23(10): 842-846
Gruhn, W.B.; Diaz-Buxo, J.A. 1987: Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyositis Journal of Rheumatology 14(5): 1045-1047
Marie, I.; Hachulla, E.; Levesque, H.; Reumont, G.; Ducrotte, P.; Cailleux, N.; Hatron, P.Y.; Devulder, B.; Courtois, H. 1999: Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis Journal of Rheumatology 26(12): 2706-2709
Krajnc, I. 1995: Anti-Jo-1-positive polymyositis with interstitial alveolitis and pericardial effusion. Overview of 3 years treatment Wiener Klinische Wochenschrift 107(19): 590-592
Pinhata, M.M.; Nascimento, J.J.; Marie, S.K.N.; Shinjo, S.K. 2015: Does previous corticosteroid treatment affect the inflammatory infiltrate found in polymyositis muscle biopsies? Clinical and Experimental Rheumatology 33(3): 310-314
Hale, G.; Waldmann, H. 1996: Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection Bone Marrow Transplantation 17(3): 305-308
Irlé, C.; Kaestli, M.; Chapuis, B.; Jeannet, M. 1985: Quantitative determination of human bone marrow T cells following in vitro depletion by Campath-1 monoclonal antibody Schweizerische Medizinische Wochenschrift 115(43): 1517-1518